Clinical Trial Update: Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial investigates mirabegron for erectile dysfunction in men with lower urinary tract symptoms due to BPH; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Erectile Dysfunction
• Prostatic Hyperplasia

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Mansoura University | Conditions: BPH, Erectile Dysfunction | Phase 2 | Status: UNKNOWN